Âé¶ą´«Ă˝É«ÇéƬ

Feature

Branches bursting with secrets

Kratom leaves contain a panoply of unidentified compounds
John Arnst
June 1, 2017

While mitragynine, 7-hydroxymitragynine and a few dozen other alkaloids make up the bulk of the 57 phytochemicals that have been isolated from kratom leaves, the plants contain a panoply of currently unidentified compounds and metabolites.

“The average plant leaf is somewhere between 35,000 and 50,000 distinct phytochemicals, and we really can identify about 1,000 if we’re lucky,” says Susan Murch, a chemist at the University of British Columbia. “You’re looking at a minimum 34,000 unknowns. In your glass of merlot, you’re looking at 7,000 unknowns; in your cup of coffee, over about 6,800 unknowns.”

The leaf of Mitragyna speciosa contains at least 34,000 unknown phytochemicals.thorporre/Wikimedia Commons

Identifying these unknown compounds and mapping their enzymatic relationships to one another by use of mathematical equations is known as metabolomics; each study can take up to three to four years due to its scale. “You do a very small mass spec analysis, and then you spend a year mining data. It’s a massive bioinformatics program,” says Murch.

Murch recently published a literature review in the Journal of Ethnopharmacology that detailed the history and chemistry of kratom and its sister species in Western medical literature with Web of Science, Google Scholar, the Royal Museum for Central Africa, the Internet Archive, the Hathi Trust and the Biodiversity Heritage Library.

Murch and her collaborator Paula N. Brown are hoping to get a metabolomics study involving kratom up and going within the next few years. “There are no metabolomics studies out there that really are definitive in terms of the different varieties, the different strains, the different things people are using,” she says.

Identifying the thousands of unknown metabolites, or intermediary components, within kratom leaves will be essential to understanding how the plant products are differently processed by populations across the globe.

“Kratom is traditionally used by a fairly specific population of Vietnam, Thailand and Southeast Asia, and so we don’t know about its nutrigenomics effects,” says Murch. “Assuming that a population in Southeast Asia will respond the same as a population anywhere else in the world is a bit of a leap of faith.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
John Arnst

John Arnst was a science writer for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.